Literature DB >> 9822632

Secondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loop.

N Richardson1, N Navaratnam, J Scott.   

Abstract

The C to U editing of apolipoprotein B (apoB) mRNA converts a glutamine codon in apoB100 mRNA into a stop translation codon thereby generating apoB48. The catalytic subunit of the editing enzyme, APOBEC-1, is an RNA-binding cytidine deaminase that requires auxiliary factors for the editing of apoB mRNA. Computer modeling and ribonuclease probing of the wild-type and mutant apoB RNA substrates reveal a stem loop at the editing site. This structure incorporates the essential sequence motifs required for editing. The localization of the edited cytidine within the loop suggests how it could be presented to the active site of APOBEC-1 for deamination. We have identified 43/45 kDa proteins from chick enterocytes and show evidence for their involvement in auxiliary editing activity. p43/45 demonstrates preferential binding to AU-rich RNA and to the Caauuug motif that forms the loop and proximal stem of the apoB mRNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822632     DOI: 10.1074/jbc.273.48.31707

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  The challenge of target sequence specificity in C-->U RNA editing.

Authors:  Nicholas O Davidson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.

Authors:  Christophe Maris; James Masse; Ann Chester; Naveenan Navaratnam; Frédéric H-T Allain
Journal:  RNA       Date:  2005-02       Impact factor: 4.942

3.  An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.

Authors:  S Anant; N O Davidson
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 4.  APOBEC-1-mediated RNA editing.

Authors:  Valerie Blanc; Nicholas O Davidson
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Sep-Oct

5.  Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.

Authors:  Martin Hersberger; Susannah Patarroyo-White; Xiaobing Qian; Kay S Arnold; Lucia Rohrer; Maureen E Balestra; Thomas L Innerarity
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

6.  Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.

Authors:  Valerie Blanc; Jeffrey O Henderson; Elizabeth P Newberry; Susan Kennedy; Jianyang Luo; Nicholas O Davidson
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

7.  Distinct roles for sequences upstream of and downstream from Physarum editing sites.

Authors:  Amy C Rhee; Benjamin H Somerlot; Neeta Parimi; Jonatha M Gott
Journal:  RNA       Date:  2009-07-15       Impact factor: 4.942

8.  Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.

Authors:  Ann Chester; Violetta Weinreb; Charles W Carter; Naveenan Navaratnam
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

9.  The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.

Authors:  Ann Chester; Angelika Somasekaram; Maria Tzimina; Adam Jarmuz; Jane Gisbourne; Raymond O'Keefe; James Scott; Naveenan Navaratnam
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

10.  The RNA-editing enzyme APOBEC1 requires heterogeneous nuclear ribonucleoprotein Q isoform 6 for efficient interaction with interleukin-8 mRNA.

Authors:  Yuko Shimizu; Hironori Nishitsuji; Hiroyuki Marusawa; Saneyuki Ujino; Hiroshi Takaku; Kunitada Shimotohno
Journal:  J Biol Chem       Date:  2014-08-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.